| Business Summary | | Bioshield
Technologies,
Inc.
historically
has
engaged
in
research
and
development,
patent
filings,
regulatory
issues
and
related
activities
geared
towards
the
sale
of
its
retail,
industrial
and
institutional
products.
Due
largely
to
recent
Environmental
Protection
Agency
approvals,
Bioshield
is
currently
selling
and
marketing
primarily
cleaning
and
deodorizing
products.
Many
of
these
products
provide
long-term
killing
action
of
microorganisms
responsible
for
cross
contamination
and
viral
contamination,
along
with
inhibiting
and
controlling
the
growth
of
over
100
viral,
bacteria,
fungi
and
yeast
organisms. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Bioshield
Technologies,
Inc,
is
a
development
stage
company
that
was
formed
to
develop,
manufacture,
and
distribute
antimicrobials
agents
and
products.
For
the
nine
months
ended
3/31/01,
net
sales
rose
35%
to
$998
thousand.
Net
loss
rose
4%
to
$13.8
million.
Revenues
reflect
a
change
in
the
business
model.
Higher
loss
reflects
higher
legal
and
accounting
expenses,
a
$1.8
million
loss
on
impairment
and
a
$1.5
million
loss
on
the
sale
of
investment. | More
from
Market Guide: Significant
Developments |
| | | | FY1999 Pay | |
| Timothy Moses, 43 Chairman | $269K | Edward Miller, 36 Interim
Pres, CEO, Director | -- | Scott Parliament, 42 CFO | -- | Douglas Moore, 63 VP
of Sales | -- | Geoffrey Faux, 44 Pres
of eMD | -- | Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|